Cookie Img
Back to top
Send SMS    Call Me Free
91-11-43536395
Home » Products » Sorafenib » Sorafenib Soranib

Sorafenib Soranib

Sorafenib Soranib
Sorafenib Soranib
Product Code : Soranib
Brand Name : Soranib
Product Specifications
  • Formulations Type
  • General Drugs
  • Formulations Form
  • Tablets
  • Treatments & Functions
  • Treat cancer occuring in the kidneys or liver
  • Gender/Age Group
  • Adult
Product Description

Our sorafenib (soranib) is basically exercised to cure kidney and liver cancer. It acts by obstructing the process of enzymes, which indicates the cells of cancer to develop and reproduce, while also restricting the blood vessels from developing inside the tumor. Thus, in this manner our drug averts the cancer from developing. As cancer of liver is third most usual cancer and kidney cancer is the most common, our medicine kills or stop the growth of the malignant cells that are typically found in these sort of cancers.

Sorafenib (soranib) minimizes the proliferation of tumor cell and has shown to limit the reproduction of cell and intracellular surface kinases. It is specified in HCC (unresectable hepatocellular carcinoma) and modern RCC (renal cell carcinoma).

Instructions for Dosage

Tablet should be taken as a whole without crushing or breaking and with water. It should also be taken without consuming food, minimum 60 to 120 minutes after having a meal. The accurate amount of dose differs relying on the situation being cured and the response of patient to the treatment. Patients are advised to consult their healthcare provider to know the precise dosage. It is advisable to never take extra amount of dosage that is prescribed by the doctor.

Side effects

There are some of the side effects, which are reported by the patients who are taking sorafenib (soranib) comprises:

  • Loss of hair
  • Fatigue
  • Acne
  • Decreased appetite
  • Loss of weight

However, there are rare chances that patients get more critical side effects related with exercising this medication. Visit your doctor or nearby healthcare provider immediately if you observe blisters on feet or hands, stomach pain, swollen limbs, bloody stools, seizures, muscle pain, dark urine, vomiting or coughing up blood and fever.

Precautions

Patients must not have any injections without consulting their doctor and must also prevent the contact with other patients or people, who have currently been vaccinated, particularly for flu or polio.

If you possess hypersensitive or allergic reaction, ask medical attention, Feasible signs comprise trouble in breathing and swallowing, chest tightness, hives, swelling and skin rashes.

Sorafenib (soranib) medication must only be exercised as prescribed and instructed by your doctor or pharmacist. It is suggested to not to adjust the amount of dose unless particularly guided to do by any of the aforesaid. Usage and dosage sometimes relies on the seriousness of the situation and the medical history of the patient and prevailing health condition.

Prior to starting the medication, make sure your doctor know about the following:

  • If you are expecting a baby or breastfeeding
  • If you suffer from any allergies
  • If you experienced any other disorders, medication conditions or illnesses, specifically high blood pressure, kidney troubles or heart problems
  • If you are on some other medications or taking any supplements or vitamins

Product Details: 

A. Name of Medicine: Soranib 
B. Chemical Used: Sorafenib 
C. Available as: Tablets
D. Strength: 200 Mg
E. Packing: 30 Tablets/120 Tablets
F. Manufacturing Company: Cipla Ltd.



Trade Information
  • Payment Terms
  • Telegraphic Transfer (T/T), Others
  • Delivery Time
  • 7-14 Days
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Main Domestic Market
  • All India

MODERN TIMES EXPORTS

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.